Partnering with Exopharm
Partner with Exopharm to jointly push the boundaries in regenerative medicine and to expedite the development of exosome-based therapies for patients. Exopharm is actively seeking partnerships with both academic research groups and biopharmaceutical companies.
Exopharm’s offerings:
- Expertise on exosome analytics, characterization, customization, and up- and downstream processing
- Access to Exopharm’s unrivaled exosome manufacturing technology for both ‘naïve’ and ‘engineered’ exosomes from a variety of cell sources
- Delivery tool for nucleic acids and small molecules
- Potential to breathe new patent life into old therapeutics
Exopharm’s proprietary LEAP manufacturing technology enables:
- Maximum yield from micro-liter bench-scale to multi-liter bioreactor scale volumes
- Full preservation of exosome integrity
- GMP purification of exosomes for clinical applications
- Fast and cost-effective exosome isolation from biofluids or culture media
Contact us to initiate partnering discussions: partnering@exopharm.com